Delisting riskPopularity #4,592
Alaunos Therapeutics (TCRT)
Preclinical developer of ALN1003, an oral small molecule for obesity.
$1.13
vs last close−0.14 (−11.02%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 3.56% | 90.4K shares | |
|---|---|---|---|
| 30 holders · as of Jun 30, 2026 | |||
| Insiders | 20.71% | 526.1K shares | |
| 6 holders · as of Aug 11, 2026 | |||
| Other | 75.73% | 1.92M shares | |
| remainder | |||
2.54M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
30 holders · 90.4K shares · 7 new positions · 13 increased · 3 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 21.4K | 0.84% | 0 | Aug 7, 2026 |
| Geode Capital Management, LLC | 19.4K | 0.76% | −3.2K | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 15.5K | 0.61% | 0 | Aug 13, 2026 |
| Vanguard Capital Management LLC | 14.1K | 0.55% | 0 | Aug 13, 2026 |
| Citadel Advisors LLC | 11.9K | 0.47% | +1.4K | Sep 2, 2026 |
| Advisor Group Holdings, Inc. | 1.7K | 0.07% | −48 | Aug 14, 2026 |
| Tower Research Capital LLC (TRC) | 1.6K | 0.06% | +38 | Aug 11, 2026 |
| SRS Capital Advisors, Inc. | 1.2K | 0.05% | +1.2Knew | Aug 10, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Postma Robert Wincl. WaterMill Asset Management Corp. | 9.00% | 199.8K | 13D | Jul 1, 2025 |
| Price Adrianincl. Chris Cole, Chris Butterworth +18 more | 8.60% | 189.1K | 13D | Mar 5, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.